2024-10-012025-09-302025-09-30false15115138STK CAPITAL INVESTMENTS LIMITED2026-06-1764304falseiso4217:GBPxbrli:pure151151382024-09-30151151382025-09-30151151382024-10-012025-09-30151151382023-09-04151151382024-09-30151151382023-09-052024-09-3015115138bus:SmallEntities2024-10-012025-09-3015115138bus:AuditExempt-NoAccountantsReport2024-10-012025-09-3015115138bus:AbridgedAccounts2024-10-012025-09-3015115138bus:PrivateLimitedCompanyLtd2024-10-012025-09-3015115138core:WithinOneYear2025-09-3015115138core:AfterOneYear2025-09-3015115138core:WithinOneYear2024-09-3015115138core:AfterOneYear2024-09-3015115138core:ShareCapital2025-09-3015115138core:SharePremium2025-09-3015115138core:RevaluationReserve2025-09-3015115138core:OtherReservesSubtotal2025-09-3015115138core:RetainedEarningsAccumulatedLosses2025-09-3015115138core:ShareCapital2024-09-3015115138core:SharePremium2024-09-3015115138core:RevaluationReserve2024-09-3015115138core:OtherReservesSubtotal2024-09-3015115138core:RetainedEarningsAccumulatedLosses2024-09-3015115138core:LandBuildings2025-09-3015115138core:PlantMachinery2025-09-3015115138core:Vehicles2025-09-3015115138core:FurnitureFittings2025-09-3015115138core:OfficeEquipment2025-09-3015115138core:NetGoodwill2025-09-3015115138core:IntangibleAssetsOtherThanGoodwill2025-09-3015115138core:ListedExchangeTraded2025-09-3015115138core:UnlistedNon-exchangeTraded2025-09-3015115138core:LandBuildings2024-09-3015115138core:PlantMachinery2024-09-3015115138core:Vehicles2024-09-3015115138core:FurnitureFittings2024-09-3015115138core:OfficeEquipment2024-09-3015115138core:NetGoodwill2024-09-3015115138core:IntangibleAssetsOtherThanGoodwill2024-09-3015115138core:ListedExchangeTraded2024-09-3015115138core:UnlistedNon-exchangeTraded2024-09-3015115138core:LandBuildings2024-10-012025-09-3015115138core:PlantMachinery2024-10-012025-09-3015115138core:Vehicles2024-10-012025-09-3015115138core:FurnitureFittings2024-10-012025-09-3015115138core:OfficeEquipment2024-10-012025-09-3015115138core:NetGoodwill2024-10-012025-09-3015115138core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3015115138core:ListedExchangeTraded2024-10-012025-09-3015115138core:UnlistedNon-exchangeTraded2024-10-012025-09-3015115138core:MoreThanFiveYears2024-10-012025-09-3015115138core:Non-currentFinancialInstruments2025-09-3015115138core:Non-currentFinancialInstruments2024-09-3015115138dpl:CostSales2024-10-012025-09-3015115138dpl:DistributionCosts2024-10-012025-09-3015115138core:LandBuildings2024-10-012025-09-3015115138core:PlantMachinery2024-10-012025-09-3015115138core:Vehicles2024-10-012025-09-3015115138core:FurnitureFittings2024-10-012025-09-3015115138core:OfficeEquipment2024-10-012025-09-3015115138dpl:AdministrativeExpenses2024-10-012025-09-3015115138core:NetGoodwill2024-10-012025-09-3015115138core:IntangibleAssetsOtherThanGoodwill2024-10-012025-09-3015115138dpl:GroupUndertakings2024-10-012025-09-3015115138dpl:ParticipatingInterests2024-10-012025-09-3015115138dpl:GroupUndertakingscore:ListedExchangeTraded2024-10-012025-09-3015115138core:ListedExchangeTraded2024-10-012025-09-3015115138dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-10-012025-09-3015115138core:UnlistedNon-exchangeTraded2024-10-012025-09-3015115138dpl:CostSales2023-09-052024-09-3015115138dpl:DistributionCosts2023-09-052024-09-3015115138core:LandBuildings2023-09-052024-09-3015115138core:PlantMachinery2023-09-052024-09-3015115138core:Vehicles2023-09-052024-09-3015115138core:FurnitureFittings2023-09-052024-09-3015115138core:OfficeEquipment2023-09-052024-09-3015115138dpl:AdministrativeExpenses2023-09-052024-09-3015115138core:NetGoodwill2023-09-052024-09-3015115138core:IntangibleAssetsOtherThanGoodwill2023-09-052024-09-3015115138dpl:GroupUndertakings2023-09-052024-09-3015115138dpl:ParticipatingInterests2023-09-052024-09-3015115138dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-052024-09-3015115138core:ListedExchangeTraded2023-09-052024-09-3015115138dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-052024-09-3015115138core:UnlistedNon-exchangeTraded2023-09-052024-09-3015115138core:NetGoodwill2025-09-3015115138core:IntangibleAssetsOtherThanGoodwill2025-09-3015115138core:LandBuildings2025-09-3015115138core:PlantMachinery2025-09-3015115138core:Vehicles2025-09-3015115138core:FurnitureFittings2025-09-3015115138core:OfficeEquipment2025-09-3015115138core:AfterOneYear2025-09-3015115138core:WithinOneYear2025-09-3015115138core:ListedExchangeTraded2025-09-3015115138core:UnlistedNon-exchangeTraded2025-09-3015115138core:ShareCapital2025-09-3015115138core:SharePremium2025-09-3015115138core:RevaluationReserve2025-09-3015115138core:OtherReservesSubtotal2025-09-3015115138core:RetainedEarningsAccumulatedLosses2025-09-3015115138core:NetGoodwill2024-09-3015115138core:IntangibleAssetsOtherThanGoodwill2024-09-3015115138core:LandBuildings2024-09-3015115138core:PlantMachinery2024-09-3015115138core:Vehicles2024-09-3015115138core:FurnitureFittings2024-09-3015115138core:OfficeEquipment2024-09-3015115138core:AfterOneYear2024-09-3015115138core:WithinOneYear2024-09-3015115138core:ListedExchangeTraded2024-09-3015115138core:UnlistedNon-exchangeTraded2024-09-3015115138core:ShareCapital2024-09-3015115138core:SharePremium2024-09-3015115138core:RevaluationReserve2024-09-3015115138core:OtherReservesSubtotal2024-09-3015115138core:RetainedEarningsAccumulatedLosses2024-09-3015115138core:NetGoodwill2023-09-0415115138core:IntangibleAssetsOtherThanGoodwill2023-09-0415115138core:LandBuildings2023-09-0415115138core:PlantMachinery2023-09-0415115138core:Vehicles2023-09-0415115138core:FurnitureFittings2023-09-0415115138core:OfficeEquipment2023-09-0415115138core:AfterOneYear2023-09-0415115138core:WithinOneYear2023-09-0415115138core:ListedExchangeTraded2023-09-0415115138core:UnlistedNon-exchangeTraded2023-09-0415115138core:ShareCapital2023-09-0415115138core:SharePremium2023-09-0415115138core:RevaluationReserve2023-09-0415115138core:OtherReservesSubtotal2023-09-0415115138core:RetainedEarningsAccumulatedLosses2023-09-0415115138core:AfterOneYear2024-10-012025-09-3015115138core:WithinOneYear2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:CostValuation2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-012025-09-3015115138core:Non-currentFinancialInstrumentscore:CostValuation2025-09-3015115138core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-09-3015115138core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3015115138core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3015115138core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3015115138core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3015115138core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3015115138core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3015115138core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3015115138core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3015115138core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3015115138bus:Director12024-10-012025-09-30

STK CAPITAL INVESTMENTS LIMITED

Registered Number
15115138
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2025

STK CAPITAL INVESTMENTS LIMITED
Company Information
for the year from 1 October 2024 to 30 September 2025

Director

KONSTANTINOS, Sophia

Company Secretary

KONSTANTINOS, Sophia

Registered Address

Wye Cottage The Street
Badwell Ash
Bury St Edmunds
IP31 3DH

Registered Number

15115138 (England and Wales)
STK CAPITAL INVESTMENTS LIMITED
Balance Sheet as at
30 September 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors997-
Cash at bank and on hand1-
998-
Creditors amounts falling due within one year4(1,223)(85)
Net current assets (liabilities)(225)(85)
Total assets less current liabilities(225)(85)
Net assets(225)(85)
Capital and reserves
Called up share capital11
Profit and loss account(226)(86)
Shareholders' funds(225)(85)
The financial statements were approved and authorised for issue by the Director on 17 June 2026, and are signed on its behalf by:
KONSTANTINOS, Sophia
Director
Registered Company No. 15115138
STK CAPITAL INVESTMENTS LIMITED
Notes to the Financial Statements
for the year ended 30 September 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Dividend income
Dividend income is recognised when the right to receive payment is established.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year11
3.Current asset investments
Current asset investments comprise short-term, highly liquid investments and bonds that are readily convertible to known amounts of cash with maturity dates of more than three months but less than one year. These are initially recognised at transaction value and subsequently measured at fair value, with changes in fair value recognised in the income statement
4.Creditors: amounts due within one year

2025

2024

££
Other creditors1,22385
Total1,22385
5.Financial instruments
The balance sheet comprises: Financial instruments held at fair value through profit and loss (2025: £997 2024: Nil); Loan creditors at amortised cost (2025: 1,224 2024: 86); Cash at bank: (2025: £2 2024: £1).
6.Share capital
Share capital ordinary shares, at nominal value of £1 each: 2025: £1 2024: £1